Merck & Co. Inc. (MRK): Price and Financial Metrics

MRK POWR Grades

• Sentiment is the dimension where MRK ranks best; there it ranks ahead of 92.26% of US stocks.
• The strongest trend for MRK is in Growth, which has been heading down over the past 177 days.
• MRK's current lowest rank is in the Momentum metric (where it is better than 17.19% of US stocks).

MRK Stock Summary

• With a market capitalization of $262,312,067,470, MERCK & CO INC has a greater market value than 99.49% of US stocks.
• MRK's went public 37.12 years ago, making it older than 93.49% of listed US stocks we're tracking.
• In terms of twelve month growth in earnings before interest and taxes, MERCK & CO INC is reporting a growth rate of 91.21%; that's higher than 84.98% of US stocks.
• Stocks that are quantitatively similar to MRK, based on their financial statements, market capitalization, and price volatility, are PFE, LLY, ASML, ABBV, and NVO.
• MRK's SEC filings can be seen here. And to visit MERCK & CO INC's official web site, go to www.merck.com.

MRK Valuation Summary

• MRK's price/sales ratio is 4.6; this is 119.05% higher than that of the median Healthcare stock.
• Over the past 243 months, MRK's price/sales ratio has gone up 2.2.

Below are key valuation metrics over time for MRK.

MRK Growth Metrics

The 5 year cash and equivalents growth rate now stands at -36.58%.
• Its 2 year price growth rate is now at 14.12%.
• Its 5 year net cashflow from operations growth rate is now at 50.65%.

MRK's revenue has moved up $17,245,000,000 over the prior 49 months.

The table below shows MRK's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	58,974	19,696	15,260
2022-06-30	57,169	18,891	16,579
2022-03-31	53,978	17,079	14,180
2021-12-31	48,704	14,109	13,049
2021-09-30	49,151	13,084	7,197
2021-06-30	48,548	10,460	5,571

MRK's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• MRK has a Quality Grade of B, ranking ahead of 77.57% of graded US stocks.
• MRK's asset turnover comes in at 0.535 -- ranking 75th of 682 Pharmaceutical Products stocks.
• XTNT, ACOR, and BDSI are the stocks whose asset turnover ratios are most correlated with MRK.

The table below shows MRK's key quality metrics over time.